30.01.2020Captor's oncological program received funding
Discovery and development of a new clinical drug candidate in the treatment of hepatocellular carcinoma...
19.12.2019New chemistry lab
We are happy to announce that our brand new chemistry lab is ready!
02.12.2019Dr Tom Shepherd joins our team
Tom Shepherd, Ph.D. as Captor Therapeutics' Chief Business Officer (CBO)...
30.07.2019Biotech of the Week in Labiotech
Labiotech about Captor Therapeutics...
17.05.2019CEBioForum Award 2019
We received the CEBioForum Award (Individual Prize)...
12.04.2019Drug Discovery Chemistry Conference in San Diego, CA
Michał Walczak, presented the therapeutic potential of small molecule protein degraders...
07.02.2019Captor Therapeutics SA received from NCBiR two grants of nearly 56 M PLN
Captor Therapeutics SA received from NCBiR two grants of...
04.01.2019Captor Therapeutics and Science of Targeted Protein Degradation
Captor Therapeutics actively participates ...
19.10.2018First TPD Conference with Michał Walczak
Michal Walczak, was invited to Targeted Protein Degradation Summit 2018...
30.08.2018Captor Therapeutics received funding for a new project
Captor Therapeutics received funding for a new R&D project to develop new therapeutics...